# IGC Pharma, Inc.: Form DEF 14A, filed Oct 22, 2026

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: DEF 14A
- Filed: 2026-10-22
- Accepted by EDGAR: Oct 21, 2026, 20:32 ET
- Period: 2026-12-02
- Accession: 0001185185-26-004896
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518526004896/igcdef14a102126.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518526004896/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518526004896/igcdef14a102126.htm

Filed Oct 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001185185-26-004896. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.